Arcede Pharma is a pharmaceutical company. The company conducts research and development in the area of chronic obstructive pulmonary disease, including abbreviated COPD, and severe asthma. The company's product portfolio includes a number of drugs intended for the treatment and alleviation of the above ailments. The largest operations are in the Nordic market. The company was established via a spin-off of Respiratorius in 2022 and is headquartered in Lund.

Quotes for Arcede Pharma AB

Right Now

+/-
0.15
%
5,45%
Latest
2.9
High
2.91
Low
2.66
Volume
1 036
Turnover (SEK)
2 884
Market Value (MSEK)
17,0
Time (Latest trade)
2022-11-29 09:46

Board

CEO

  • Mia Lundblad

Chairperson of the Board

  • Ingemar Kihlström

Board

  • Åsa Kornfeld
  • Johanna Asklin
  • Laurent Pacheco

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 11,24 11,24 2022-09-28
Avanza Pension 7,89 7,89 2022-09-28
Valcuria Holding AB 3,86 3,86 2022-09-28
Ben Hayes 2,34 2,34 2022-09-28
Hans Harvig 2,24 2,24 2022-09-28
Nordnet Pensionsförsäkring 1,45 1,45 2022-09-28
Benny Bengtsson 1,17 1,17 2022-09-28
Andreas Bylin 1,17 1,17 2022-09-28
Arian Ismail 1,03 1,03 2022-09-28
Göran Lennart Rehn 0,99 0,99 2022-09-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-12-05 Delårsrapport 2023-Q2

  • 2023-05-12 Årsstämma 2023

Annual reports, prospectus etc.